Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thymus Neoplasms × Erlotinib Hydrochloride × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 122 Lung Neoplasms 46 Pancreatic Neoplasms 29 Non-Squamous Non-Small Cell Lung Cancer 15 Neoplasms 15 Glioblastoma 12 Gliosarcoma 11 Breast Neoplasms 11 Adenocarcinoma of Lung 11 Brain Neoplasms 10 Neoplasm Metastasis 9 Head and Neck Neoplasms 9 Carcinoma, Renal Cell 7 Carcinoma, Hepatocellular 7 Carcinoma, Squamous Cell 6 Astrocytoma 6 Adenocarcinoma, Bronchiolo-Alveolar 6 Squamous Cell Carcinoma of Head and Neck 5 Oligodendroglioma 5 Urinary Bladder Neoplasms 4 Glioma 4 Esophageal Neoplasms 4 Colorectal Neoplasms 4 Carcinoma 4 Adenocarcinoma 4 Recurrence 3 Rectal Neoplasms 3 Ovarian Neoplasms 3 Liver Neoplasms 3 Kidney Neoplasms 3

Interventions

ribociclib 1 pembrolizumab 1 napabucasin 1 epacadostat 1 amrubicin 1 Sunitinib 1 Plicamycin 1 Paclitaxel 1 Nivolumab 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡